World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
123
Citations
60792
World Ranking
3329
National Ranking
336

Immunology

D-Index
116
Citations
50330
World Ranking
376
National Ranking
32

Paul D. Griffiths publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul D. Griffiths sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 879 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul D. Griffiths D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul D. Griffiths sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 116 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul D. Griffiths is affiliated with University College London in the United Kingdom. Their research primarily focuses on medicine, with significant contributions to epidemiology, infectious diseases, immunology, parasitology, and economics and econometrics as subfields.

The scientist's main research topics include:

  • Cytomegalovirus and herpesvirus research
  • Herpesvirus infections and treatments
  • Parvovirus B19 infection studies
  • Toxoplasma gondii research studies
  • Immune cell function and interaction
  • Viral-associated cancers and disorders
  • Mosquito-borne diseases and control

Recent publications authored or co-authored by Paul D. Griffiths illustrate their active involvement in viral pathogenesis and infection prevention. Selected papers include:

  • Pathogenesis of human cytomegalovirus in the immunocompromised host, 2021, Nature Reviews Microbiology
  • Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank, 2022, Nature Communications
  • Prevention of Acquisition of Cytomegalovirus Infection in Pregnancy Through Hygiene-based Behavioral Interventions: A Systematic Review and Gap Analysis, 2020, The Pediatric Infectious Disease Journal
  • The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination, 2020, Antiviral Research
  • The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread, 2023, Nature Communications

Paul D. Griffiths has frequently collaborated with a number of co-authors, notable among them:

  • Claire Atkinson
  • Matthew B. Reeves
  • Judith Breuer
  • Christine E. Jones
  • Soren Gantt

The scientist has published in multiple venues, with recurrent appearances in:

  • Reviews in Medical Virology
  • Nature Communications
  • Transfusion Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases

Additionally, Paul D. Griffiths has authored a book published by Springer International Publishing titled Corporate Governance in the Knowledge Economy (2021).

Best Publications

  • Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients

    Per Ljungman;Paul Griffiths;Carlos Paya

  • The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.

    Michael Gossop;Shane Darke;Paul Griffiths;Julie Hando

  • Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

    Louisa Degenhardt;Amy Peacock;Samantha Colledge;Janni Leung

  • UKESM1: Description and Evaluation of the U.K. Earth System Model

    Alistair A. Sellar;Colin G. Jones;Jane P. Mulcahy;Yongming Tang

  • Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

    Amy Peacock;Amy Peacock;Janni Leung;Sarah Larney;Sarah Larney;Samantha Colledge

  • Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

    Per Ljungman;Per Ljungman;Michael Boeckh;Michael Boeckh;Hans H Hirsch;Filip Josephson

  • Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysis

    Mohamed Zuhair;G. Suzanne A. Smit;G. Suzanne A. Smit;G. Suzanne A. Smit;Gabriel Wallis;Faiz Jabbar

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    D. W. Kimberlin;P. M. Jester;P. J. Sánchez;A. Ahmed

  • Genetic content of wild-type human cytomegalovirus

    Aidan Dolan;Charles Cunningham;Ralph D. Hector;Aycan F. Hassan-Walker

  • The pathogenesis of human cytomegalovirus

    Paul Griffiths;Ilona Baraniak;Matt Reeves

  • Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

    Vincent C Emery;Caroline A Sabin;Alethea V Cope;Dehila Gor

  • Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

    L Papagno;C A Spina;A Marchant;M Salio

  • Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study.

    P B Sullivan;B Lambert;M Rose;M Ford-Adams

  • Pathogenesis of human cytomegalovirus in the immunocompromised host.

    Paul Griffiths;Matthew Reeves

  • Investigating the functional anatomy of empathy and forgiveness.

    Tom F. D. Farrow;Ying Zheng;Iain D. Wilkinson;Sean A. Spence

  • Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

    Paul D Griffiths;Anna Stanton;Erin McCarrell;Colette Smith

  • Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

    Sarah Larney;Amy Peacock;Janni Leung;Samantha Colledge

  • Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis.

    Christoph Ort;Alexander L. N. van Nuijs;Jean-Daniel Berset;Lubertus Bijlsma

  • Severity of dependence and route of administration of heroin, cocaine and amphetamines

    Michael Gossop;Paul Griffiths;Beverly Powis;John Strang

  • Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

    Anne A. Gershon;Michael D. Gershon;Judith Breuer;Myron J. Levin

  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

    David W. Kimberlin;Penelope M. Jester;Pablo J. Sánchez;Amina Ahmed

Frequent Co-Authors

Vincent C. Emery
Vincent C. Emery University of Surrey
Margaret Johnson
Margaret Johnson The Royal Free Hospital
Caroline Sabin
Caroline Sabin University College London
Mike Sharland
Mike Sharland St George's, University of London
Richard J. Whitley
Richard J. Whitley University of Alabama at Birmingham
Jane A. McKeating
Jane A. McKeating University of Oxford
Mark D. Kilby
Mark D. Kilby University of Birmingham
Stephen C. Robson
Stephen C. Robson Newcastle University
George Janossy
George Janossy University of the Witwatersrand
Andrew N. Phillips
Andrew N. Phillips University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse career paths in healthcare and research. For those interested in advancing their clinical expertise, exploring fnp to acute care np pathways can provide critical skills for treating severe and complex conditions, enhancing patient outcomes.

Nurses looking to accelerate their careers may consider accelerated rn to np programs, which offer a streamlined route to becoming nurse practitioners. These programs combine rigorous training with flexible online formats, ideal for working professionals.

For those new to nursing, several online rn programs for non nurses provide foundational education, making the transition into healthcare smoother while balancing other life commitments.

Understanding compensation trends is also essential. The dnp salary by specialty gives valuable insights into salary variations across different roles and states, guiding students and professionals in making informed career decisions.

Best Scientists Citing Paul D. Griffiths

Trending Scientists

Recently Published Articles